Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GONAL-f® RFF Redi-ject® safely and effectively. See full prescribing information for GONAL-f® RFF Redi-ject® GONAL-f® RFF Redi-ject® (follitropin alfa) injection for subcutaneous use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Prior to initiation of treatment with GONAL-f® RFF Redi-ject®: Perform a complete gynecologic and endocrinologic evaluation Exclude primary ovarian failure Exclude the possibility of pregnancy Demonstrate tubal patency Evaluate the fertility status of the male partner Prior to initiation of treatment with GONAL-f® RFF Redi-ject ® : Perform a complete gynecologic and endocrinologic evaluation, and diagnose the cause of infertility Exclude the possibility of pregnancy Evaluate the fertility status of the male partner
- generic_name
- follitropin
- product_names
- FOLLITROPIN
- ndc
- 44087-1115, 44087-1115-1, 44087-1116, 44087-1116-1, 44087-1117, 44087-1117-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en